Literature DB >> 33936269

Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population.

Alexandra Neagu1, Adela-Ioana Mocanu2, Alexandru Bonciu3, Gabriella Coadă4, Horia Mocanu5.   

Abstract

Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene, GJB2, which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene, 35delG and W24X in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the 35delG mutation 35delG/35delG), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group 35delG/W24X. The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the 35delG and W24X mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  Connexin Cx26; DNA mutational analysis; GJB2; environment; gene frequency; risk factors; sensorineural hearing loss

Year:  2021        PMID: 33936269      PMCID: PMC8082587          DOI: 10.3892/etm.2021.10044

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  29 in total

1.  Genetic testing as part of the early hearing detection and intervention (EHDI) process.

Authors:  Lisa A Schimmenti; Ariadna Martinez; Michelle Fox; Barbara Crandall; Nina Shapiro; Milhan Telatar; Yvonne Sininger; Wayne W Grody; Christina G S Palmer
Journal:  Genet Med       Date:  2004 Nov-Dec       Impact factor: 8.822

2.  Mutations of the Connexin 26 gene in families with non-syndromic hearing loss.

Authors:  Walid Al-Achkar; Faten Moassass; Bassel Al-Halabi; Ayman Al-Ablog
Journal:  Mol Med Rep       Date:  2011-01-25       Impact factor: 2.952

3.  Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands.

Authors:  Arti Pandya; Kathleen S Arnos; Xia J Xia; Katherine O Welch; Susan H Blanton; Thomas B Friedman; Guillermina Garcia Sanchez; Xiu Z Liu MD; Robert Morell; Walter E Nance
Journal:  Genet Med       Date:  2003 Jul-Aug       Impact factor: 8.822

Review 4.  Hereditary deafness and phenotyping in humans.

Authors:  Maria Bitner-Glindzicz
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

5.  Prevalence of the c.35delG and p.W24X mutations in the GJB2 gene in patients with nonsyndromic hearing loss from North-West Romania.

Authors:  C Lazăr; R Popp; A Trifa; C Mocanu; G Mihut; C Al-Khzouz; E Tomescu; I Figan; P Grigorescu-Sido
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-01-21       Impact factor: 1.675

6.  High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG.

Authors:  P Gasparini; R Rabionet; G Barbujani; S Melçhionda; M Petersen; K Brøndum-Nielsen; A Metspalu; E Oitmaa; M Pisano; P Fortina; L Zelante; X Estivill
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

7.  [DNA diagnosis in congenital and early childhood hypoacusis and deafness].

Authors:  T G Markova; S M Megrelishvilli; N G Zaĭtseva; I A Shagina; A V Poliakov
Journal:  Vestn Otorinolaringol       Date:  2002

8.  Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus.

Authors:  A Grifa; C A Wagner; L D'Ambrosio; S Melchionda; F Bernardi; N Lopez-Bigas; R Rabionet; M Arbones; M D Monica; X Estivill; L Zelante; F Lang; P Gasparini
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

9.  Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans.

Authors:  L Zelante; P Gasparini; X Estivill; S Melchionda; L D'Agruma; N Govea; M Milá; M D Monica; J Lutfi; M Shohat; E Mansfield; K Delgrosso; E Rappaport; S Surrey; P Fortina
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

10.  Factors influencing parental decision about genetics evaluation for their deaf or hard-of-hearing child.

Authors:  Christina G S Palmer; Jason T Lueddeke; Jin Zhou
Journal:  Genet Med       Date:  2009-04       Impact factor: 8.822

View more
  4 in total

Review 1.  Genetic etiology of hearing loss in Iran.

Authors:  Mojgan Babanejad; Maryam Beheshtian; Fereshteh Jamshidi; Marzieh Mohseni; Kevin T Booth; Kimia Kahrizi; Hossein Najmabadi
Journal:  Hum Genet       Date:  2022-01-20       Impact factor: 4.132

2.  Quality of life and tracheostomy influence in successfully treated hypopharyngeal cancer: A case report.

Authors:  Alina-Georgiana Vulcu Cordunianu; Gabriel Ganea; Mihai Alexandru Cordunianu; Daniel Cochior
Journal:  Exp Ther Med       Date:  2022-01-05       Impact factor: 2.447

3.  Rare and unusual benign tumors of the sinonasal tract and pharynx: Case series and literature review.

Authors:  Horia Mocanu; Adela-Ioana Mocanu; Cosmin Moldovan; Ioana Soare; Paraschiva A Postolache; Alexandru Nechifor
Journal:  Exp Ther Med       Date:  2022-03-16       Impact factor: 2.447

4.  Analysis of long-term anatomic results of radical mastoidectomy.

Authors:  Horia Mocanu; Adela-Ioana Mocanu; Gabriella Coadă; Alexandru Bonciu; Mihai-Adrian Schipor; Marian Rădulescu
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.